Skip to main content

Peer Review reports

From: Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

Original Submission
3 Aug 2021 Submitted Original manuscript
22 Nov 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
23 Dec 2021 Editorially accepted
19 Jan 2022 Article published 10.1186/s13063-021-05977-0

You can find further information about peer review here.

Back to article page